(Q38156452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Carbonyl reduction pathways in drug metabolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Vladimír Wsól

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Petra Malátková

series ordinal

1

1 reference

29 August 2017

Vladimír Wsól

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

31 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

published in

Drug Metabolism Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

96-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3).

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Characterization of htAKR, a novel gene product in the aldo-keto reductase family specifically expressed in human testis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

HPLC determination of tolperisone in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Metabolism of Synthetic Steroids by the Human Placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Mechanisms and resistance in glucocorticoid control of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The aldo-keto reductase superfamily and its role in drug metabolism and detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

New antiepileptic drugs that are second generation to existing antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The metabolism of betamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacology of fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Advances in human cytochrome p450 and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Characterization of a novel type of human microsomal 3alpha -hydroxysteroid dehydrogenase: unique tissue distribution and catalytic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Enantiomers of warfarin and vitamin K1 metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Identification of Metabolic Pathways Involved in the Biotransformation of Tolperisone by Human Microsomal Enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Ultra-performance liquid chromatography- tandem mass spectrometry method for the determination of bupropion and its main metabolites in human whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

A passion for P450s (rememberances of the early history of research on cytochrome P450).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Overview of the clinical pharmacokinetics of oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Three fatal drug overdoses involving bupropion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Synthesis and structure-activity relationships of novel warfarin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

cDNA cloning and characterization of a new human microsomal NAD+-dependent dehydrogenase that oxidizes all-trans-retinol and 3alpha-hydroxysteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Systematic overview of warfarin and its drug and food interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Use of high-performance liquid chromatography to characterize the rapid decomposition of wortmannin in tissue culture media

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Aldo-keto reductases in the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Steroid biosynthesis inhibitors in the therapy of hypercortisolism: theory and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo-keto reductase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Aldo-keto reductases and bioactivation/detoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Drug interactions involving the new second- and third-generation antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Genetic and clinical factors relating to warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Glucocorticoid-resistant asthma and novel anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Discovery of cyclicsulfonamide derivatives as 11 beta-hydroxysteroid dehydrogenase 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Use of chiral liquid chromatography for the evaluation of stereospecificity in the carbonyl reduction of potential benzo[c]fluorene antineoplastics benfluron and dimefluron in various species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Drug disposition in the mammalian eye and brain: a comparison of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

l-bunolol metabolites in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Warfarin metabolism in man: identification of metabolites in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Human carbonyl reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Multiplicity of mammalian reductases for xenobiotic carbonyl compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Contrasting influence of NADPH and a NADPH-regenerating system on the metabolism of carbonyl-containing compounds in hepatic microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Nabumetone kinetics in the young and elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

A fatal case of bupropion (Zyban) overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Intermittent claudication: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

New developments in anthracycline-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Transplacental passage of oxcarbazepine and its metabolites in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Structural basis for substrate specificity in human monomeric carbonyl reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Kinetic and structural evidence of the alkenal/one reductase specificity of human ζ-crystallin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Effects of fibrates on metabolism of statins in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Human carbonyl reduction pathways and a strategy for their study in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Fenofibric acid for hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Molecular design for enhancement of ocular penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Enzyme stereospecificity as a powerful tool in searching for new enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Pharmacokinetics of tibolone in early and late postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

In vitro glucuronidation of fenofibric acid by human UDP-glucuronosyltransferases and liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

In vitro metabolism and identification of human enzymes involved in the metabolism of methylnaltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Characterization of a major form of human isatin reductase and the reduced metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Rapid high-performance liquid chromatography-tandem mass spectrometry method for determination of pentoxifylline and its active metabolites M1 and M5 in human plasma and its application in bioavailability study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The in vivo human metabolism of tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Bupropion metabolism by human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Simultaneous quantitative determination of bupropion and its three major metabolites in human umbilical cord plasma and placental tissue using high-performance liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Species differences in the chirality of the carbonyl reduction of [14C] fenofibrate in laboratory animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Genomic profiling in nuclear receptor-mediated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Microarray Analysis of the Global Alterations in the Gene Expression in the Placentas From Cigarette-smoking Mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

Metabolism of Fibric Acid Derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2013.853078

10.3109/03602532.2013.853078

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json

release_3lv555pujver3fgjtyvpjvsqe4

28 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3lv555pujver3fgjtyvpjvsqe4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171394%20AND%20SRC:MED&resulttype=core&format=json